Skip to main content
logo
  • Healthcare professional
  • LFB Group
Logo Equilibrium
X
  • Home
  • About EquilYbrium
    • Steering Committee members
  • Immunodeficiencies
    • Primary Immunodeficiencies
      • ADVANCED CARE IN PID: From birth to adulthood: LFB Symposium IPIC 2015
      • THE IMMUNOLOGIST CONSULTATION; Recognizing the signs of X-linked agammaglobulinemia
      • NEW INSIGHTS IN THE USE OF INTRAVENOUS IMMUNOGLOBULINS: How to enhance PID patients clinical outcomes ?
    • Secondary Immunodeficiencies
      • SID IN A HEART TRANSPLANT PATIENT
      • SID IN CLL PATIENT
  • Immunomodulation
    • Guillain-Barré Syndrome (GBS)
      • Guillain Barré Syndrome : From diagnosis to treatment
    • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
      • CIDP Educational Slides Deck
      • New insights in the use of intravenous
        immunoglobulins
      • Serious game: NeuroSims
      • CIDP response to Ig: What, When and How?
      • CIDP: Early treatment escalation in non-IVIg responders. A debate
    • Multifocal Motor neuropathy (MMN)
      • Evidence - based medicine and current advances in multifocal motor neuropathy
    • Congresses highlights
      • PNS 2020 Congress - Selected research presentation
      • PNS - ICNMD 2022 congresses - Selected research presentations
    • Guidelines
      • EAN/PNS CIDP Guidelines 2021 - Dr. Luis Querol Lecture
  • Research Grant

Healthcare professionals

You can connect using your Onekey Web authentication account to access to the contents reserved for you.

By using the link below, you quit temporarly the LFB portal.

Sign in via OWA
My space
  • Home
  • About EquilYbrium
    • Steering Committee members
  • Immunodeficiencies
    • Primary Immunodeficiencies
      • ADVANCED CARE IN PID: From birth to adulthood: LFB Symposium IPIC 2015
      • THE IMMUNOLOGIST CONSULTATION; Recognizing the signs of X-linked agammaglobulinemia
      • NEW INSIGHTS IN THE USE OF INTRAVENOUS IMMUNOGLOBULINS: How to enhance PID patients clinical outcomes ?
    • Secondary Immunodeficiencies
      • SID IN A HEART TRANSPLANT PATIENT
      • SID IN CLL PATIENT
  • Immunomodulation
    • Guillain-Barré Syndrome (GBS)
      • Guillain Barré Syndrome : From diagnosis to treatment
    • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
      • CIDP Educational Slides Deck
      • New insights in the use of intravenous
        immunoglobulins
      • Serious game: NeuroSims
      • CIDP response to Ig: What, When and How?
      • CIDP: Early treatment escalation in non-IVIg responders. A debate
    • Multifocal Motor neuropathy (MMN)
      • Evidence - based medicine and current advances in multifocal motor neuropathy
    • Congresses highlights
      • PNS 2020 Congress - Selected research presentation
      • PNS - ICNMD 2022 congresses - Selected research presentations
    • Guidelines
      • EAN/PNS CIDP Guidelines 2021 - Dr. Luis Querol Lecture
  • Research Grant
  • LFB Group

Public site

  • Home
  • About EquilYbrium
  • Immunodeficiencies
  • Immunomodulation
  • Other Therapeutic Uses
  • Contact
  • Sitemap
  • CGU
  • D-19-0180

This activity is funded by LFB.
D-19-0180

You will be redirected to the page : Presentation of the Grant

I accept ▸